ClinicalTrials.Veeva

Menu

Expression of G-protein Coupled Receptor 120 Receptor in Adipose Tissue of German Diabetes Center Cohort Subjects (GPR120)

G

German Diabetes Center

Status

Completed

Conditions

Type 2 Diabetes

Study type

Observational

Funder types

Other

Identifiers

NCT03285750
GPR120 study

Details and patient eligibility

About

G-protein coupled receptor 120 (GPR120) is a G-protein-coupled receptor whose endogenous ligands have been identified as long-chain fatty acids. Recently, it has been shown that GPR120 expression in human adipose tissue is higher in obese than in lean individuals. Interestingly, a GPR120 deficient mouse model presents an unfavorable phenotype when fed a high-fat diet with obesity, glucose intolerance and fatty liver, characteristics also found in type 2 diabetes (T2D).

Moreover, in obese subjects, a single nucleotide polymorphism (R270H) has been identified that inhibits GPR120 signaling activity.

The investigators now want to investigate if GPR120 expression in adipose tissue may be altered in patients with T2D compared to non-diabetic subjects and might contribute to diabetes-associated metabolic changes. Additionally, the investigators want to assess the frequency of the R270H mutant in T2D.

Enrollment

50 patients

Sex

All

Ages

20 to 69 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Type 2 diabetes mellitus / normoglycemia
  • BMI < 27,5 or > 30 kg/m2
  • Age 20 - 69 years

Exclusion criteria

  • severe chronic diseases
  • anemia
  • medication altering fatty acid metabolism

Trial design

50 participants in 2 patient groups

Diabetic group
Description:
Patients with recently diagnosed type 2 diabetes
Controls
Description:
Age- and BMI-matched normoglycemic subjects

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems